RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles

Displaying items 12-22
  • EU regulator warns on possible MS drugs side effects

    FRANKFURT (Reuters) - Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs. A...
  • P&G eyes Duracell, Braun in sweeping brand culling: sources

    NEW YORK (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said....
  • 'Plantibodies' drugs advance as big pharma stands aside

    LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies. The leading...
  • Achillion's hepatitis C drug shows promise in trial

    (Reuters) - Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. The mid-stage trial tested Achillion's...
  • FDA approves Belsomra, a new prescription sleep drug

    FDA approves Belsomra, a new prescription sleep drug
    The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...
  • Healthcare: A remedy for long-term investors

    CHICAGO (Reuters) - (The opinions expressed here are those of the author, a columnist for Reuters.) For healthcare, gray is the new black. The fastest-growing segment of the global population is aged 60 and over, according to the United Nations...
  • Pfizer Slightly Beats Expectations, Leaves Investors Guessing About AstraZeneca

    Pfizer Inc on Tuesday left investors guessing whether it would renew its pursuit of its British rival, AstraZeneca, but said it was considering other deals. The largest U.S. drug maker reported higher-than-expected second-quarter revenue, helped by...
  • The day ahead in business

    The day ahead in business
    Reports: July consumer confidence, S&P Case-Shiller home price index for May, Redbook and ICSC-Godlman Sachs retail sales for period ending July 28 Local earnings: A.M. Castle & Co., Anixter International Inc., Arthur J. Gallagher & Co., Calamos Asset...
  • Who gains from those drug discount deals? (Spoiler: Drug companies)

    The pharmaceutical industry has been bragging for nearly a decade now about its efforts to help cash-strapped patients pay for expensive prescription drugs.  "An important safety net," the industry says, that has "already helped millions of Americans...
  • Merck supera estimaciones, nuevos medicamentos contrarrestan menores ventas de genéricos

    (Reuters) - Merck & Co reportó resultados trimestrales mejores de lo esperado, ya que las ventas de sus nuevos fármacos compensaron una caída en las ventas de medicamentos que enfrentan la competencia de genéricos. La segunda mayor farmacéutica de...
  • MetLife, Developer To Build $110 Million Industrial Distribution Center Near Atlanta

    MetLife Inc. announced Thursday it is teaming with a California developer to build a $110 million industrial distribution center near Hartsfield-Jackson Atlanta International Airport in Georgia. The New York life insurer, which has operations in...